Clinical Trials Browser

Phase NA × Hodgkin Disease × Dacarbazine × Clear all

NCT01868451 2025-07-09

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Phase NA Active not recruiting

Hodgkin Disease